HLA-DQ Gene Complementation and Other Histocompatibility Relationships in Man with the Anti-Ro/SSA Autoantibody Response of Systemic Lupus Erythematosus

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1990 Aug 1

PMID 1974555

Citations 15

Authors

A Fujisaku

M B FRANK

B Neas

M Reichlin

J B Harley

Affiliations

Soon will be listed here.

Abstract

A strong gene interaction between HLA-DQ1 and DQ2 alleles has been associated with anti-Ro/SSA autoantibodies (Harley, J.B., M. Reichlin, F. C. Arnett, E. L. Alexander, W. B. Bias, and T. T. Provost. 1986. Science [Wash. DC]. 232:1145-1147; Harley, J. B., A. S. Sestak, L. G. Willis, S. M. Fu, J. A. Hansen, and M. Reichlin. 1989. Arthritis Rheum. 32:826-836; Hamilton, R. G., J. B. Harley, W. B. Bias, M. Roebber, M. Reichlin, M. C. Hochberg, and F. C. Arnett. 1988. Arthritis Rheum. 31:496-505). To test a gene complementation mechanism for these results, restriction fragment length polymorphisms (RFLP) of the DQ alpha and DQ beta genes have been related to Ro/SSA precipitins in patients with systemic lupus erythematosus. In this study Ro/SSA precipitins are related to the simultaneous presence of a particular pair of RFLPs. A DQ alpha RFLP associated with HLA-DQ1 and a DQ beta RFLP associated with HLA-DQ2 predict that the alpha beta heterodimer in HLA-DQ1/DQ2 heteroxygotes is most closely related to anti-Ro/SSA autoantibodies, thereby supporting a gene complementation mechanism. Beyond this effect, an RFLP associated with HLA-DQ2 and/or DR7 is also related to Ro/SSA precipitins. Multiple molecular histocompatibility mechanisms are implicated, therefore, in the production of anti-Ro/SSA autoantibodies in autoimmune disease. For anti-Ro/SSA autoantibodies in SLE, and perhaps more generally, these data show that the histocompatibility antigens are among the elements that confer autoimmune response specificity and restrict the production of particular autoantibodies among patients with systemic lupus erythematosus.

Citing Articles

HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis.

Favoino E, Urso L, Serafino A, Misceo F, Catacchio G, Prete M J Clin Med. 2021; 10(14).

PMID: 34300172 PMC: 8305973. DOI: 10.3390/jcm10143006.

Degree of modification of Ro60 by the lipid peroxidation by-product 4-hydroxy-2-nonenal may differentially induce Sjögren syndrome or systemic lupus erythematosus in BALB/c mice.

Kurien B, Porter A, Dorri Y, Iqbal S, Dsouza A, Singh A Free Radic Biol Med. 2010; 50(10):1222-33.

PMID: 20946951 PMC: 3591494. DOI: 10.1016/j.freeradbiomed.2010.10.687.

MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus.

McHugh N, Owen P, Cox B, Dunphy J, Welsh K Ann Rheum Dis. 2005; 65(4):488-94.

PMID: 16107511 PMC: 1798099. DOI: 10.1136/ard.2005.039842.

A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution.

Scofield R, Warren W, Koelsch G, Harley J Proc Natl Acad Sci U S A. 1993; 90(20):9330-4.

PMID: 8415702 PMC: 47561. DOI: 10.1073/pnas.90.20.9330.

No direct correlation between HLA-DPB1 and antibodies against recombinant Ro (SS-A)/La (SS-B) proteins in systemic lupus erythematosus. SLE Study Group.

Yao Z, Hartung K, Ehrfeld H, Seelig H, Deicher H, Brunnler G Rheumatol Int. 1993; 13(4):155-8.

PMID: 8310208 DOI: 10.1007/BF00301263.

References

Rosenshine S, Cascino I, Zeevi A, Duquesnoy R, Trucco M . DQ alpha and beta RFLP reveals the composition of the DQ molecule recognized by T-cell clones. Immunogenetics. 1986; 23(3):187-96. DOI: 10.1007/BF00373820. View

Harley J, Alexander E, Bias W, Fox O, Provost T, Reichlin M . Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum. 1986; 29(2):196-206. DOI: 10.1002/art.1780290207. View

Hamilton R, Harley J, Bias W, Roebber M, Reichlin M, Hochberg M . Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum. 1988; 31(4):496-505. DOI: 10.1002/art.1780310406. View

Ben-Chetrit E, Chan E, Sullivan K, Tan E . A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med. 1988; 167(5):1560-71. PMC: 2188933. DOI: 10.1084/jem.167.5.1560. View

Kwok W, Schwarz D, Nepom B, Hock R, Thurtle P, Nepom G . HLA-DQ molecules form alpha-beta heterodimers of mixed allotype. J Immunol. 1988; 141(9):3123-7. View

Deutscher S, Harley J, Keene J . Molecular analysis of the 60-kDa human Ro ribonucleoprotein. Proc Natl Acad Sci U S A. 1988; 85(24):9479-83. PMC: 282776. DOI: 10.1073/pnas.85.24.9479. View

Mond C, Peterson M, Rothfield N . Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum. 1989; 32(2):202-4. DOI: 10.1002/anr.1780320213. View

Ben-Chetrit E, Gandy B, Tan E, Sullivan K . Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen. J Clin Invest. 1989; 83(4):1284-92. PMC: 303819. DOI: 10.1172/JCI114013. View

Rader M, OBrien C, Liu Y, Harley J, Reichlin M . Heterogeneity of the Ro/SSA antigen. Different molecular forms in lymphocytes and red blood cells. J Clin Invest. 1989; 83(4):1293-8. PMC: 303820. DOI: 10.1172/JCI114014. View

10.

Harley J, Sestak A, Willis L, Fu S, Hansen J, Reichlin M . A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum. 1989; 32(7):826-36. View

11.

Reichlin M, Rader M, Harley J . Autoimmune response to the Ro/SSA particle is directed to the human antigen. Clin Exp Immunol. 1989; 76(3):373-7. PMC: 1541897. View

12.

Long E, Wake C, Gorski J, MACH B . Complete sequence of an HLA-dR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes. EMBO J. 1983; 2(3):389-94. PMC: 555145. DOI: 10.1002/j.1460-2075.1983.tb01435.x. View

13.

Clark G, Reichlin M, TOMASI Jr T . Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus. J Immunol. 1969; 102(1):117-22. View

14.

Dorf M, Benacerraf B . Complementation of H-2-linked Ir genes in the mouse. Proc Natl Acad Sci U S A. 1975; 72(9):3671-5. PMC: 433058. DOI: 10.1073/pnas.72.9.3671. View

15.

Southern E . Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975; 98(3):503-17. DOI: 10.1016/s0022-2836(75)80083-0. View

16.

Maddison P, Mogavero H, Reichlin M . Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein. J Rheumatol. 1978; 5(4):407-11. View

17.

Maddison P, Reichlin M . Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus. Arthritis Rheum. 1979; 22(8):858-63. DOI: 10.1002/art.1780220808. View

18.

Wasicek C, Reichlin M . Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest. 1982; 69(4):835-43. PMC: 370138. DOI: 10.1172/jci110523. View

19.

Larhammar D, Schenning L, Gustafsson K, Wiman K, Claesson L, Rask L . Complete amino acid sequence of an HLA-DR antigen-like beta chain as predicted from the nucleotide sequence: similarities with immunoglobulins and HLA-A, -B, and -C antigens. Proc Natl Acad Sci U S A. 1982; 79(12):3687-91. PMC: 346491. DOI: 10.1073/pnas.79.12.3687. View

20.

Ahearn J, Provost T, Dorsch C, STEVENS M, Bias W, Arnett F . Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 1982; 25(9):1031-40. DOI: 10.1002/art.1780250901. View